Universe Pharmaceuticals Inc.
UPC
Rank in Stocks
#32967
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise... Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Share Price
$1.60
Last synced: 2026-11-09
Market Cap
$1.01M
Change (1 day)
15.11%
Change (1 year)
-55.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Universe Pharmaceuticals Inc. (UPC)
Category
Healthcare
EPS for Universe Pharmaceuticals Inc. (UPC)
EPS as of March 2026 TTM: $-3.45
According to Universe Pharmaceuticals Inc.'s latest financial reports, its current EPS (TTM) is $-3.45. At the end of 2025 the company had an EPS of $-1.06K, an increase over its 2024 EPS of $-1.44K.
EPS history for Universe Pharmaceuticals Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-3.45 | -99.67% |
| 2025 | $-1.06K | -26.49% |
| 2024 | $-1.44K | 38.02% |
| 2023 | $-1.04K | -29.46% |
| 2022 | $-1.48K | -168.70% |
| 2021 | $2.15K | 65.72% |
| 2020 | $1.30K | 0.09% |
| 2019 | $1.29K | -0.68% |
| 2018 | $1.30K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -288.45% |
DE
|
|
| $6.08 | -276.16% |
DE
|
|
| $1.55 | -144.94% |
JP
|
|
| $3.66 | -206.09% |
CH
|
|
| $0.45 | -113.04% |
IL
|
Questions about Universe Pharmaceuticals Inc.'s earnings per share (EPS)
What is Universe Pharmaceuticals Inc.'s earnings per share (EPS)?
Universe Pharmaceuticals Inc.'s earnings per share (EPS) over the last twelve months is $-3.45, as of Mar 2026.
What was Universe Pharmaceuticals Inc.'s earnings per share (EPS) in 2025?
In 2025, Universe Pharmaceuticals Inc.'s earnings per share (EPS) was $-1.06K, compared with $-1.44K in 2024.
How has Universe Pharmaceuticals Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Universe Pharmaceuticals Inc.'s earnings per share (EPS) was highest in 2021 ($2.15K) and lowest in 2022 ($-1.48K).
How does Universe Pharmaceuticals Inc.'s earnings per share (EPS) compare with similar companies?
Universe Pharmaceuticals Inc.'s earnings per share (EPS) ($-3.45) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.